LAG3 and neoplasm: In other words, tumor cells and other cells from the tumor microenvironment can promote an immune privilege status by releasing immunosuppressive cytokines or modulating the expression of immunoregulatory molecules to induce T cell anergy or tolerance, such as the immune checkpoint molecules of B7 family, and LAG3 [6, 7].